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Introduction
Evidence from scores of observational studies from
many parts of the world have demonstrated an association between elevated blood total homocysteine
levels and the risk of cardiovascular disease, peripheral vascular disease, and stroke {l,2}. These conditions are more prevalent in males than in females in
virtually all populations studied, and their prevalence
increases with advancing age. A much smaller body of
data exists that describes an increasing tendency to
higher homocysteine levels with increasing age.
There have been no previous reports of blood
homocysteine levels measured in a cross-sectional
sample throughout the age spectrum from childhood through the elderly. However, the Third
National Health and Nutrition Examination Survey
(NHANES III) in the United States provides such a
representative sample. We present here the results of
the homocysteine analyses on 10,000 samples of serum representing ages 12 years to 100 years in both
males and females.

The Third National Health and
Nutrition Examination Survey
(NHANES III): 1988-1994
The U.S. National Center for Health Statistics has
conducted six health examination surveys of the U.S.

population since 1960, and has recently completed
NHANES III {3}. The surveys are designed to obtain
nationally representative information about the
health and nutrition status of American populations
through interviews and direct physical examinations.
Physical examinations are employed because the information collected either cannot be furnished or is
not available in a standardized manner through interviews with the people themselves or through records
maintained by health professionals who provide their
medical care.
The goals of NHANES III are: (1) to estimate
the national prevalence of selected disease and
risk factors, (2) to provide national population
reference distributions of selected health parameters,
(3) to document and investigate reasons for secular
trends and selected diseases and risk factors, (4) to
contribute to an understanding of disease etiology,
and (5) to investigate the natural history of selected
diseases.
The eligible population for this NHANES III is
the U.S. civilian noninstitutionalized population ages
2 months or older {4}. The sample design utilizes a
stratified multistage probability sample of counties,
blocks, and persons randomly selected from households. The periods from 1988-1991 and 1991-1994
each constitute national samples of the U.S. population as well as all six years combined. Eighty-one
counties were selected from 26 states, from which
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approximately 40,000 persons were selected and
30,000 agreed to participate. In the period from
1988-1991 (Phase I), 20,277 persons were selected
for the sample. Of those, 17,464 were interviewed
and 15,630 (77%) have participated in the Examination. Precise estimates of health characteristics are
needed for specific subgroups of the population (children <5 years, persons 60 years and older, black
Americans and Mexican Americans) and these groups

TABLE 25-1. Sampling
subdomains by race and age: NHANES III

Mrican-American

White and all other

2-35 months

2-11 months
12-35 months
3-5 years
6-11 years
12-19 years
20-29 years
30-39 years
40-49 years
50-59 years
60-69 years
70-79 years
80 years and over

3-5 years
6-11 years
12-19 years
20-39 years
40-59 years
60 years and over

MexicanAmerican

2-35 months
3-5 years
6-11 years
12-19 years
20-29 years
40-49 years
60 years and
over

TABLE 25-2. Diseases studied in NHANES III
heart disease
asthma, chronic
bronchitis, emphysema
diabetes
kidney disease and other
urologic disorders
gall bladder disease
osteoporosis
arthritis
infectious disease

dental caries and periodontal
disease
allergies
depression
hearing loss
vision problems
iron-deficiency anemia
obesity

TABLE 25-3. Nutrition assessment in NHANES III
Dietary/nutrient intake
Anthropometric measutments
Nutritional biochemistries and hematologic tests
Physical examination
Interview

are being selected in greater numbers than would
have occurred without oversampling.
NHANES III data collection began in the fall of
1988 and was completed in the fall of 1994. Over the
6-year survey, more than 36,000 persons were interviewed, and more than 30,000 completed a standardized detailed physical examination in specially
equipped mobile examination centers that traversed
the country. The survey was conducted in two consecutive 3-year phases and designed so that each phase
was a national probability sample. Table 25-1 presents the sampling scheme for NHANES III, which
was designed to enroll a minimum of 560 individuals
in each of the 52 sex, race, and age strata. Serum
samples for the determination of homocysteine were
derived from Phase II of this survey. We have already
received all samples for participants aged 12 and
older, and measured homocysteine concentrations on
samples from 1,981 men and 2,401 women to date.
When completed, we anticipate that homocysteine
values will be available for greater than 10,000 survey
participants ages 12 through 100 years. We also
plan to determine homocysteine levels on approximately 3,000 samples from participants aged 3 to 11
years.
The data collected in this survey will be used to
estimate the prevalence of major diseases and nutrition disorders, as well as potential risk factors.
NHANES III data will also be the basis for national
standards that measure height,. weight, and blood
pressure. Data from NHANES III will be used in
epidemiologic and health science research to direct
and design health programs and services and expand
the health knowledge for the nation.
As in the past Health Examination Surveys, data
from NHANES III will describe the prevalence of
chronic conditions in the population, data on previously undiagnosed conditions, and those known to
and reported by the survey respondent. The diseases
TABLE 25-4. Nutritional biochemistry analysis
in NHANES III
Retionl and retinyl esters
Carotene profile
Selenium
Calcium, total and ionized
Vitamin A, vitamin C, vitamin D, vitamin E
Serum iron: total iron binding capacity
Serum ferritin and protoporphyrin
Serum and red cell folate
Serum homocysteine
Serum methylmalonic acid
Vitamin B12
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and medical conditions to be studied are included in
table 25-2. Table 25-3 lists the methods and procedures used to assess nutritional status. Table 25-4
lists the nutritional biochemical measures used to
assess micronutrient status in this survey.

were held at -70°C for periods ranging from eight
months to 3 years before they were analyzed for
homocysteine.
Homocysteine measurements were carried out at
the USDA Human Nutrition Research Center on
Aging using the method of Araki and Sato [5}. The
preliminary results presented here are based on a
sample of 1,981 males and 2,401 females aged 12102 years. The mean age for both men and women
was 43.8 years. The age-adjusted geometric mean
homocysteine concentrations for men and women
were 9.8 and 8.0~mollL respectively (fig. 25-1).
Homocysteine concentrations increased continuously
with age for men and women, and were greater for
men at all ages (fig. 25-2). In men, geometric mean
concentrations increased by 63% across the age range
presented here, from 7. 7 ~mol/L at ages 12-19 years
to 12.4~mol/L in the 85+-year-old age group. For
women, geometric mean homocysteine concentrations increased 75%, from 6.4 to 11.2 ~mollL across
the ages considered here.
There was a significant age-sex interaction (p <
0.001), indicating that the age relations differed in
men and women. The age-related increase in

Serum Homocysteine in NHANES III
Having serum homocysteine analyses available from a
large representative sample of U.S. population (n =
15,000, age ~ than 3) with an oversampling for elderly and minority groups, a complete physical examination, hematology, serum and urinary biochemical
data, anthropometry/body composition, dietary data,
and information on supplement use, etc., provides a
remarkable opportunity for analysis. Blood was drawn
on participants whose fasting status was variable but
recorded. Whole blood was held at room temperature
for 30-60 minutes prior to centrifugation. Sera were
separated and frozen at -20°C and transferred
to the Centers for Disease Control and Prevention's
central laboratory for priority analyses. Some
samples went through numerous freeze cycles.
After priority analyses were complete, the surplus sera
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FIGURE 25-1. Distribution of serum homocysteine concentrations in 1981 men (-) and 2401 women (-), ages 12 to
102 years: Preliminary results from NHANES III.
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homocysteine appeared to be continuous and gradual
in men except for an abrupt 23% increase between
the 12-19 and 20-29 year-old age groups. This resulted in a more than 30% higher concentration in
men than in women, a difference that was largely
sustained until women approached the age of 50. At
this age, concentrations in women appear to increase
more rapidly with age than those in men, substantially reducing the sex-related difference in
homocysteine concentrations to approximately 12%
by ages 60-69 years, a relative difference that is maintained over the next two decades of life.
Our results are consistent with observations from
other large samples. The Hordaland Homocysteine
Srudy [6} examined 7,591 men and 8,585 women
ages 40-67 years with no history of vascular disease,
diabetes, or hypertension. In the youngest participants (ages 40-42), homocysteine concentrations in
men were 19% greater than those in women. This
difference diminished to 11 % in the oldest age group
considered (65-67 years). Homocysteine concentrations increased 13% in men and 21 % in women from
age 40-42 years to age 65-67 years. Brattstrom and
colleagues [7} examined a much smaller sample of
131 men and 113 women across a broader age range
(35-95 years). They also observed that men had
higher homocysteine concentrations than women at
every age. In the youngest age groups (35-49 years),
concentrations in men exceeded those in women by
11 %; in the oldest age group (80-95 years) these

FIGURE 25-2. Geometric mean of serum homocysteine
concentrations and 95 % confidence intervals by age decade
in 1981 men (circles) and 2401 women (squares): Preliminary data results from NHANES III.

concentrations were 9% greater in men. In men, a
steady increase in homocysteine over the age groups
resulted in a 60% greater homocysteine concentration
in the men ages 80-95 years compared with those
who were 35-49 years old. In contrast, concentrations in women did not appear to increase until approximately age 65 years, when they demonstrated an
approximately 20% increase. By age 80, the concentrations in women, just as in men and similar to what
we report here, had risen approximately 60% from
the youngest age group considered.
Using data from the original Framingham cohort
who were 67-96 years of age, we previously reported
[8} that homocysteine concentrations were 10%
higher in men than in women under age 75 years of
age, and that the sex difference was reduced in the
older age groups. We also reported that homocysteine
concentrations continued to increase across this
range of older ages. We observed a 20% increase in
homocysteine in this older cohort even across the
fairly narrow (29-year) age range. Much of this increase was seen for those subjects over age 80. We
have also noted very similar age and sex relations with
homocysteine in the Framingham Offspring cohort,
in which we have collected data on men and women
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ages 26-83 years (unpublished observations), and in
these preliminary NHANES III data.
Although the analyses of NHANES III
homocysteine data in relation to nutrient intake,
blood folate levels, and measures of vitamin B12 status
are yet to be made, and the associations with measures
of renal function have not yet been performed,
this rich body of information awaits analysis in association with a variety of nutrition diseases and
anthropometric variables. In the absence of any of
these other analyses, it would be prematute to speculate on the mechanism of this increase in blood
homocysteine throughout the age spectrum, or on the
consistent gender difference of males always being
higher.
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